Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
For pricing and availability of generic Indian daclatasvir as on 7 March 2016, Please
click here
.
March 29, 2016
/
News
Related
Posts
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Hepatitis C Treatment Snapshots: Daclatasvir
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Strategies to Secure Access to Generic HCV Medicines
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Asia Pacific Situational Updates on Generic DAAs – June 2017
